Pre-earnings options volume in Viking Therapeutics (VKTX) is normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move near 7.6%, or $2.38, after results are released. Median move over the past eight quarters is 7.8%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Options Volatility and Implied Earnings Moves Today, October 22, 2025
- Viking Therapeutics initiates VK2735 maintenance dosing clinical trial
- Options Volatility and Implied Earnings Moves This Week, October 20 – October 24, 2025
- Is VKTX a Buy, Before Earnings?
- Viking Therapeutics: Promising Position in GLP-1 Market with Strategic Growth Potential